Targeted Medical Pharma, Inc. (TRGM) has 14 open-market insider trades by 6 insiders since 2013. The most active filer is William Shell, CEO & Chief Scientific Officer & 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Charuvastra Exemption Trust Elizabeth | CEO & Chief Scientific Officer10% | — | 2 | $200K | 2014-08-12 |
| William Shell | CEO & Chief Scientific Officer10% | — | 4 | $95K | 2014-05-28 |
| Charuvastra & William Shell Family Trust Elizabeth | 10% | — | 1 | $32K | 2013-06-20 |
| Kim Giffoni | CEO | — | 4 | $21K | 2016-03-04 |
| Arthur R. Nemiroff | Dir | — | 1 | $8K | 2013-11-19 |
| Family Trust Dated September 26 2008 Giffoni | 10% | — | 2 | $522 | 2015-11-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Family Trust Dated September 26 2008 Giffoni | 10% | Sell | $172 | 2015-11-24 |
| Family Trust Dated September 26 2008 Giffoni | 10% | Buy | $350 | 2014-11-24 |
| Charuvastra Exemption Trust Elizabeth | CEO & Chief Scientific Officer & 10% | Sell | $40K | 2014-08-12 |
| Charuvastra Exemption Trust Elizabeth | CEO & Chief Scientific Officer & 10% | Sell | $160K | 2014-07-24 |
| William Shell | CEO & Chief Scientific Officer & 10% | Sell | $1K | 2014-05-28 |
| William Shell | CEO & Chief Scientific Officer & 10% |
Companies that share insiders with TRGM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sell |
| $2K |
| 2014-05-27 |
| William Shell | CEO & Chief Scientific Officer & 10% | Sell | $90K | 2014-04-10 |
| Kim Giffoni | EVP Foreign Sales/Inv. Rel. & 10% | Buy | $4K | 2014-04-09 |
| Kim Giffoni | EVP Foreign Sales/Inv. Rel. | Buy | $900 | 2013-12-12 |
| Kim Giffoni | EVP Foreign Sales/Inv. Rel. | Buy | $11K | 2013-12-09 |
| Kim Giffoni | EVP Foreign Sales/Inv. Rel. & 10% | Buy | $5K | 2013-11-27 |
| Arthur R. Nemiroff | Director | Sell | $8K | 2013-11-19 |
| William Shell | CEO & Chief Scientific Officer & 10% | Sell | $2K | 2013-09-13 |
| Charuvastra & William Shell Family Trust Elizabeth | 10% | Buy | $32K | 2013-06-20 |